Clearing bile duct stones in pregnant women
Endoscopic Common Bile Duct Stones Clearance During Pregnancy: Challenges and Solutions
This study looks at how safely and effectively doctors can remove bile duct stones from pregnant women using special techniques to protect both the mother and baby.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | Female |
| Sponsor | South Valley University Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Qinā) |
| Trial ID | NCT06092905 on ClinicalTrials.gov |
What this trial studies
This observational study analyzes the outcomes of endoscopic clearance of common bile duct stones in pregnant patients experiencing symptomatic choledocholithiasis from June 2015 to June 2023. The approach involves using safe sedation and anesthesia techniques, performing the procedure in a left lateral decubitus position to accommodate the pregnant uterus, and utilizing trans-abdominal ultrasound instead of fluoroscopy to minimize radiation exposure. Data on perioperative outcomes and follow-up will be collected and analyzed to assess the effectiveness and safety of this method.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women who are experiencing symptoms related to common bile duct stones.
Not a fit: Patients with pancreatitis or cholangitis will not benefit from this study as they are excluded from participation.
Why it matters
Potential benefit: If successful, this study could provide a safer method for treating bile duct stones in pregnant women, reducing risks associated with traditional procedures.
How similar studies have performed: While this approach is innovative in the context of pregnancy, similar studies have shown success in endoscopic procedures for bile duct stones in non-pregnant populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women with symptomatic common bile duct stones. Exclusion Criteria: * Presence of pancreatitis or cholangitis.
Where this trial is running
Qinā
- Qena Faculty of Medicine, South Valley University Hospitals — Qinā, Egypt (Recruiting)
Study contacts
- Principal investigator: Abdallah M Aly, Md — South Valley University
- Study coordinator: Abdallah M Aly, Md
- Email: abdallahsurgery@med.svu.edu.eg
- Phone: +201011716497
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.